Ifosfamide
Who holds supplier records for Ifosfamide? 8 organisations hold a current record for Ifosfamide: an active US FDA Type II Drug Master File or a CEP. 1 of them holds a valid EU Certificate of Suitability. Recorded organisation countries for current records: Poland (2), China (2), India (1), United States (1) and 1 other country (1); not recorded for 1.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Ifosfamide: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/ifosfamide
Reading the evidence
- 8 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 2 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (8)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Ifosfamide. Country is the organisation's recorded country, not necessarily the manufacturing site.
- AARTI PHARMALABS LIMITEDIndiaActive DMF 25081 · latest filing Jul 2009
- BAXTER HEALTHCARE CORPUnited StatesActive DMF 3506 · latest filing Apr 1979
- CHEMWERTH INCFranceActive DMF 42098 · latest filing Apr 2026
- IFOTAM CO LTDPolandActive DMF 15064 · latest filing Sept 2000
- JIANGSU HENGRUI PHARMACEUTICALS CO LTDChina Company GMP cert on recordActive DMF 11290 · latest filing Jan 1995
- Sichuan Huiyu Pharmaceutical Co., Ltd.China Company GMP cert on recordActive DMF 44513 · latest filing Sept 2026
- ZYPHAR'S BIOPHARMACEUTICALS PRIVATE LTDActive DMF 44717 · latest filing Aug 2026
- TARCHOMINSKIE ZAKLADY FARMACEUTYCZNE POLFA S.A.PolandCEPValid CEP holder (EDQM); not necessarily the manufacturer
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (1)
Certificates of Suitability on the EDQM register for Ifosfamide, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 2 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| TARCHOMINSKIE ZAKLADY FARMACEUTYCZNE POLFA S.A. Warsaw | PL | CEP 2006-238 - Rev 02 Ifosfamide | Aug 2024 | Inspected May 2026 Poland |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Overview
Ifosfamide is an alkylating agent used as a chemotherapy drug for treating various cancers, including testicular cancer. It is structurally related to cyclophosphamide and functions by interfering with the replication of cancer cells.
Chemical identity
- IUPAC name
- N,3-bis(2-chloroethyl)-2-oxo-1,3,2lambda5-oxazaphosphinan-2-amine
- Canonical SMILES
- C1CN(P(=O)(OC1)NCCCl)CCCl
- InChIKey
- HOMGKSMUEGBAAB-UHFFFAOYSA-N
- Synonyms
- Ifex API, ifex, isocyclophosphamide, isophosphamide, mjf 9325, mjf-9325, nsc-109724, z-4942, z4942
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Alkylating Drug
- Mechanism of action
- Alkylating Activity
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Ifosfamide?
8 organisations hold an active US FDA Type II Drug Master File or a CEP for Ifosfamide: AARTI PHARMALABS LIMITED (India), BAXTER HEALTHCARE CORP (United States), CHEMWERTH INC (France), IFOTAM CO LTD (Poland), JIANGSU HENGRUI PHARMACEUTICALS CO LTD (China), Sichuan Huiyu Pharmaceutical Co., Ltd. (China), ZYPHAR'S BIOPHARMACEUTICALS PRIVATE LTD and TARCHOMINSKIE ZAKLADY FARMACEUTYCZNE POLFA S.A. (Poland). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Ifosfamide Drug Master Files are active?
AARTI PHARMALABS LIMITED (DMF 25081), BAXTER HEALTHCARE CORP (DMF 3506), CHEMWERTH INC (DMF 42098), IFOTAM CO LTD (DMF 15064), JIANGSU HENGRUI PHARMACEUTICALS CO LTD (DMF 11290), Sichuan Huiyu Pharmaceutical Co., Ltd. (DMF 44513) and ZYPHAR'S BIOPHARMACEUTICALS PRIVATE LTD (DMF 44717). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
Does Ifosfamide have a European Certificate of Suitability?
Yes. 1 organisation holds a valid CEP for Ifosfamide on the EDQM register, including TARCHOMINSKIE ZAKLADY FARMACEUTYCZNE POLFA S.A. Warsaw (PL). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Ifosfamide supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Ifosfamide?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.